BELKIN Vision

company

About

BELKIN Vision is developing an automated, fast glaucoma laser device, aimed at revolutionizing accessibility to glaucoma care worldwide.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
€17.50M
Industries
Health Care,Laser,Medical Device
Founded date
Mar 21, 2013
Number Of Employee
11 - 50
Operating Status
Active

BELKIN Vision is developing an automated, fast glaucoma laser treatment, aimed at revolutionizing accessibility to glaucoma care by becoming the first-line choice for glaucoma therapy for every patient, all over the world.
BELKIN Vision is addressing the growing disparity between the enormous number of glaucoma patients (67M) and the limited number of ophthalmologists (212,000), by enabling the doctor to treat many more patients quickly.
BELKIN’s innovative technology is applicable for the prevalent Open Angle Glaucoma (OAG, 70% of total glaucoma patients) and it will pioneer laser treatment for Angle Closure Glaucoma (ACG, 30%), which is most common among Asian populations.
• The innovative solution provides treatment that is patient friendly - non-invasive, non-contact, instantaneous & painless.
• BELKIN Laser has the opportunity to completely transform the conventional glaucoma treatment from a specialized procedure performed mainly by glaucoma specialists, into a treatment that is effective, safe and reliable which can be carried out by all ophthalmologists and other healthcare providers.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
€17.50M $18.85M
BELKIN Vision has raised a total of €17.50M $18.85M in funding over 2 rounds. Their latest funding was raised on Dec 20, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 20, 2021 Grant €17.50M 1 European Innovation Council Detail
Jul 21, 2020 Series B $12.25M 1 Santen Ventures Detail
Jun 5, 2017 Series A $6.60M 1 Zicom Holdings Detail

Investors

Number of Lead Investors
Number of Investors
3
3
BELKIN Vision is funded by 3 investors. European Innovation Council and Santen Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Grant
Santen Ventures Yes Series B
Zicom Holdings Yes Series A